Atlas Trials

Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease

Clinical trial NCT03709771 · TERMINATED

Trial details

NCT number
NCT03709771
Sponsor
Vanderbilt University Medical Center
Status
TERMINATED
Study type
OBSERVATIONAL
Renal Cell CarcinomaHypertensionMelanomaCancer
Start date
2020-01-09
Primary completion
2020-10-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.